A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives

Abstract

The results of this study indicate that a number of the characteristics of the women taking COCs affect the risk of VTE. There is no evidence to support the hypothesis that there is any difference in risk between COC formulations containing under 50 microg ethinyloestradiol.